Cambrex is a Pharmaceutical company, Manufacturer/Innovator, Contract Service, CMO/CDMO, Biopharmaceutical company company operating in the pharmaceutical industry.
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,400 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.
Company type
Pharmaceutical company, Manufacturer/Innovator, Contract Service, CMO/CDMO, Biopharmaceutical company
Products and services
Biopharmaceuticals, Custom Manufacturing, Intermediates, Fine and Specialty Chemicals, Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Cambrex on LinkedIn
Address
Cambrex, One Meadowlands Plaza, East Rutherford, NJ, United States, 7073
